To further explore altered phospho-PR promoter selectivity (Fig. 1a), we conducted global gene expression analyses in T47D breast cancer cells expressing either WT or K388R PR-B receptors treated as above (Fig. 4a). This evidence concerns the gene PGR and breast cancer.